
FDAãCOVID-19ã¯ã¯ãã³ãæ¿èªããŠä»¥æ¥ã53.5äžäººã®ç±³åœã®åäŸãšè¥è ãæ»äº¡ãéå°æ»äº¡ã50%å¢å ãCDCã®ç§å¯ã¬ããŒããå ¬è¡š
å èšäºã¯ãã¡ããã/Click here to read the original article.
ç±³åœçŸç 管çã»ã³ã¿ãŒïŒCDCïŒãå¯ãã«çºè¡šããè¡æçãªå ±åæžã«ãããçæã®SARS-CoV-2ãŠã€ã«ã¹ã«å¯Ÿãã解決çãšããŠå®£äŒãããŠããCOVID-19ã¯ã¯ãã³ããå®éã«ã¯ç±³åœã®åäŸãè¥å¹Žå±€ã«çããã害ãäžããŠããå¯èœæ§ãããããšãæããã«ãªããŸããã
ç±³åœçŸç 管çã»ã³ã¿ãŒïŒCDCïŒã«ãããšãFDAãCOVIDã¯ã¯ãã³ã®ç·æ¥äœ¿çšèš±å¯ãäžããŠããããªããš535,000人ãã®åäŸãè¥è ã亡ããªã£ãŠããŸãã

ããã¯ãCOVID-19ãã³ãããã¯æçæã®2020å¹Žãšæ¯èŒããŠããã®å¹Žéœ¢å±€ã®è¶ éæ»äº¡ã50ïŒ å¢å ããããšãæå³ããŸãã

ãããããã®åé¡ã«çŽé¢ããŠããã®ã¯ãã¢ã¡ãªã«ã ãã§ã¯ãããŸããã

è±åœæ¿åºã®åœå®¶çµ±èšå±ãçºè¡šããå ¬åŒå ±åæžã«ãããšãã³ããã19ãæ¥çš®ããåã©ãã¯ãã¯ã¯ãã³æªæ¥çš®ã®åã©ãã«æ¯ã¹ãŠãäœããã®åå ã§æ»äº¡ãã確çã4423ïŒ ïŒ45åïŒãã³ããã19ã§æ»äº¡ãã確çã13633ïŒ ïŒ137åïŒãšããé©ç°çãªæ°åã«ãªã£ãŠããŸãã

ãããã®çµæã¯ææ ®ãã¹ããã®ã§ãããCOVID-19ã¯ã¯ãã³æ¥çš®ã®å®å šæ§ãšæå¹æ§ã«æ·±å»ãªæžå¿µãæ±ããããã®ã§ãã
ãã®ãããªè¡æçãªçµ±èšã«ãããããããç±³åœãšè±åœã®äž¡æ¿åºã¯ãCOVID-19ã¯ã¯ãã³ã®ç·æ¥äœ¿çšèªå¯ãè±åœã§ã¯5æ³å ãç±³åœã§ã¯6ã«æå ã«ãŸã§æ¡å€§ããæ¥çš®åæ°ãå¢ããããåããããç¶ããŠããŸãã

ã¯ã¯ãã³ã¯ãçæã®COVID-19ç ãããã¹ãŠã®äººãå®ãããã«èšèšããããšèšãããŠããŸããããã®ããŒã¿ã¯ãã¯ã¯ãã³ãã®ãã®ãéå°æ»äº¡ã®é©ãã¹ãå¢å ã®åå ã«ãªã£ãŠããå¯èœæ§ã瀺åããŠããŸãã
è±åœæ¿åºã®åœå®¶çµ±èšå±ãæè¿çºè¡šãããã¯ã¯ãã³æ¥çš®ãåããåäŸã®æ»äº¡æ°ãé©ãã»ã©å¢å ããŠãããšããå ±åãåããŠãå€ãã®äººããã®çŸè±¡ã®åå ã¯äœã ãããšèããŠããŸãã
ã©ã¡ãã®å ±åæžãå ·äœçãªæ»å ã«ã€ããŠã¯èšåããŠããŸããããå»åŠã®å°éå®¶ãæå±ããŠããããã€ãã®å¯èœæ§ããããŸãã
æãæžå¿µãããåå ã®ã²ãšã€ã¯ãCOVID-19ã¯ã¯ãã³ãå¿èã«äžããæªåœ±é¿ã§ããæè¿ã®ç ç©¶ã§ã¯ãã³ããã-19ã¯ã¯ãã³ããç¹ã«è¥å¹Žå±€ã§å¿ççãšããŠç¥ãããå¿èã®ççãåŒãèµ·ããå¯èœæ§ãããããšã瀺ãããŠããŸãã
å¿ççã¯ãå¿çã«ççãèµ·ããããã®çµæãå¿èã匱ããæ£åžžã«æ©èœããªããªãå¯èœæ§ããããŸããå¿ççã®çç¶ã«ã¯ãèžã®çã¿ãæ¯åããç²åŽãæ¥éãŸãã¯äžèŠåãªå¿æãå«ãŸããããšããããŸãã

å¿ççã¯éçåãããšãå¿äžå šãå¿åæ¢ããããã¯æ»ã«è³ãããšããããŸãã
ã¯ã¯ãã³æ¥çš®åŸã®å¿ççã®æ£ç¢ºãªåå ã¯ãŸã å®å šã«ã¯è§£æãããŠããŸããããã¯ã¯ãã³ã«ãã£ãŠåŒãèµ·ããããå ç«åå¿ã誀ã£ãŠå¿èã®çµç¹ãæ»æããŠããŸãããšãåå ã§ã¯ãªãããšèããå°éå®¶ãããŸãã
ã¯ã¯ãã³æ¥çš®ãåããåã©ããã¡ã®æ»äº¡ãå¢å ããŠããããäžã€ã®çç±ã¯ãè¡å°æ¿æžå°çå矀ïŒTTSïŒãšåŒã°ããå¥åŠã§çããã¿ã€ãã®è¡æ¶²ååºé害ãåºçŸããŠããããšã§ãããšèããããŸãã
ãã®çŸæ£ã¯ãã¢ã¹ãã©ãŒãã«ç€Ÿããã³ãžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ç€Ÿã®COVID-19ã¯ã¯ãã³ãæ¥çš®ããå€ãã®äººã«èгå¯ãããŠãããã¯ã¯ãã³ã«å¯Ÿããå ç«åå¿ã«ãã£ãŠåŒãèµ·ãããããšèããããŠããã
ããããç±³åœCDCãšè±åœMHRAã®äž¡æ¹ãçºè¡šããããŒã¿ã§ã¯ããã¡ã€ã¶ãŒç€Ÿãšã¢ãã瀟ã®mRNAéºäŒåæ²»çæ³šå°ãåãçç¶ãåŒãèµ·ãããŠããããšã確èªãããŠããŸãã
ãŸããäžéšã®å»çå°éå®¶ã¯ãCOVID-19ã¯ã¯ãã³ã®é·æçãªåœ±é¿ã®å¯èœæ§ãç¹ã«çºééäžã®åã©ãã®èº«äœãå ç«ç³»ãžã®åœ±é¿ã«ã€ããŠæžå¿µã瀺ããŠããŸãããã®ã¯ã¯ãã³ã¯ããŸã ååã«çè§£ããç ç©¶ãããŠããªããåã©ãã®å¥åº·ã«äºæãã¬çµæãããããå¯èœæ§ããããŸãã
ãã®ãããªæœåšçãªãªã¹ã¯ãæžå¿µãããã«ãããããããå€ãã®æ¿åºã補è¬äŒç€Ÿã¯ãã¡ãªããããªã¹ã¯ãäžåããšäž»åŒµããã¯ã¯ãã³æ¥çš®ã®æ®åãæšé²ãç¶ããŠããŸãã
ããããè±åœåœå®¶çµ±èšå±ãç±³åœCDCãçºè¡šããæè¿ã®èª¿æ»çµæã¯ãç¹ã«åã©ããã¡ã«ãšã£ãŠãããã§ã¯ãªãããšã瀺åããŠããŸãã

ãããã®ç¥èŠãèžãŸããçŸåšãå€ãã®å°éå®¶ããå°å ã«å¯ŸããCOVID-19ã¯ã¯ãã³æ¥çš®ã®ãªã¹ã¯ãšãããã£ãããåè©äŸ¡ããããæ±ããŠããŸããéç¯€ãªæå®³äºè±¡ã®ãªã¹ã¯ã¯ãã¯ã¯ãã³æ¥çš®ã®æœåšçãªå©çãšæ éã«æ¯èŒæ€èšãããªããã°ãªãããç¹ã«COVID-19ãå°å ã«ãããããªã¹ã¯ãäœãããšãèæ ®ãããšããã®ãããªããšã¯ã§ããŸããã

COVID-19ã¯ã¯ãã³æ¥çš®ã®å®å šæ§ã«åãã蚌æ ãçžæ¬¡ãã§ããã«ããããããã補è¬äŒç€Ÿãæ¿åºã¯ãã¯ã¯ãã³æ¥çš®ãå®å šã§æå¹ã§ãããšäž»åŒµãããããªãæ¥çš®ãæšé²ãç¶ããŠããŸããããããçŸåšãå€ãã®å°éå®¶ããç¹ã«åã©ãã«å¯Ÿãããããã®ã¯ã¯ãã³æ¥çš®ã®ãªã¹ã¯ãšãããã£ãããåè©äŸ¡ããããšãæ±ããŠããŸãã
COVID-19ã®äºé²æ¥çš®ã®å®å šæ§ãšæå¹æ§ãããã£ãŠãè±åœãšç±³åœããçºè¡šãããããŒã¿ã¯ãå»çé¢ä¿è ãäžè¬ã®äººã ã®éã§ç±ãè°è«ãåŒã³èµ·ããã«éããªãã§ãããã
ãã®äºé²æ¥çš®ãåããäœçŸäžäººãã®åã©ããè¥è ã®æªæ¥ãã©ããªããã¯ãæéãçµã£ãŠã¿ãªããã°ããããŸãããããšãããããè¡æçãªäºå®ãæããã«ãããã®ã§ãã
ã³ããã19ã®äºé²æ¥çš®ã¯ãåãããå®³ã®æ¹ãã¯ããã«å€ãã®ã§ãã